MOSCHESE, DAVIDE

MOSCHESE, DAVIDE  

Dipartimento di Scienze Biomediche e Cliniche  

Mostra records
Risultati 1 - 20 di 80 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Mental health, stigma and risk perception among early adopters of HIV PrEP with LA Cabotegravir in Italy: a multicenter cross-sectional and implementation study 2026 Moschese, DavideFusetti, ChiaraCossu, Maria VittoriaLazzarin, SamuelGiacomelli, AndreaGori, Andrea + Article (author) -
Management of asymptomatic bacterial STIs and doxycycline postexposure prophylaxis: consensus statement of the Italian Society of Infectious and Tropical Diseases 2026 Andrea GiacomelliDavide Moschese + Article (author) -
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort 2026 Monforte, A d'ArminioAntinori, SMarchetti, G CMonforte, A d'ArminioGiacomelli, AGori, AMarchetti, GPerno, C FBandera, AMonforte, A d'ArminioGiacomelli, AGori, ALai, AMarchetti, GRusconi, STincati, CRovito, RPiconi, SAntinori, SGori, ABandera, AAugello, MMoschese, D + Article (author) -
Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis 2026 Davide MoscheseChiara FusettiSamuel LazzarinAndrea GiacomelliDario CattaneoFrancesco CarusoDonatella MaddalenaFrancesco PetriAndrea Gori + Article (author) -
Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV on Any Antiretroviral Therapy Regimen: The Retrospective ESSENTIAL Study 2026 Cossu M. V.Moschese D.Riva A.Giacomelli A.Gori A. + Article (author) -
Extreme Cardiovascular Risk and LDL-C Target Achievement in People With HIV 2026 Giacomelli A.Moschese D.Gori A. + Article (author) -
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 2026 Monforte, Antonella d'ArminioRusconi, StefanoMarchetti, GiuliaGiacomelli, AndreaAntinori, S.Marchetti, G. C.Giacomelli, A.Gori, A.Bandera, A.Giacomelli, A.Lai, A.Piconi, S.Rossotti, R.Taramasso, L.Tincati, C.Rovito, R.Menzaghi, B.Piconi, S.Canavesi, G.Antinori, S.Bandera, A.Cossu, M. V.Moioli, M. C.Carrozzo, G.Augello, M.Moschese, D. + Article (author) -
Impact of sex, age and body composition on rilpivirine and cabotegravir trough concentrations in people with HIV receiving long-acting injectable antiretroviral therapy 2026 Andrea RabbioneMaddalena MatoneAndrea GiacomelliDavide MoscheseAndrea Gori + Article (author) -
Authors' response: Addressing the blind spot of self-reported adherence in the era of long-acting PrEP 2026 Moschese, DavideGori, Andrea + Article (author) -
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153 2025 Moschese D.Sabaini F.Antinori S. + Article (author) -
High effectiveness of ceftriaxone monotherapy and limited value of routine test-of-cure for Gonorrhoea in a low-resistance setting 2025 Chiara FusettiFederica SalariAndrea GiacomelliFrancesco CarusoAgostino RivaAndrea GoriDavide Moschese + Article (author) -
Effectiveness and safety of tenofovir alafenamide/emtricitabine/bictegravir as a first-line regimen in people with HIV: A retrospective observational study 2025 Andrea GiacomelliDavide MoscheseSerena ReatoFederico SabainiGiacomo PozzaMartina Laura ColomboChiara FusettiSpinello AntinoriAndrea Gori + Article (author) -
Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study) 2025 Moschese, DavideGiacomelli, Andrea + Article (author) -
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025 2025 Moschese, DavideMaddalena, DonatellaPetri, FrancescoMatone, MaddalenaGiacomelli, AndreaVisigalli, DeboraRiva, AgostinoGori, Andrea + Article (author) -
Evolution of causes of death in People with HIV between 2000 and 2023: a single center retrospective Study 2025 Carrozzo, GiorgiaPozza, GiacomoPoloni, AndreaCaronni, StefaniaCossu, Maria VittoriaMoschese, DavideMatone, MaddalenaRiva, AgostinoAntinori, SpinelloGori, AndreaGiacomelli, Andrea + Article (author) -
Deltoid Administration of LAI-ART: Pharmacokinetic Implications When the Gluteal Site Is Not Feasible 2025 Cossu, Maria VittoriaMoschese, DavideGori, AndreaCattaneo, Dario + Article (author) -
High Rates of Drug Use and Chemsex Among PrEP Users and People with HIV in Milan Highlight Need for Targeted Interventions 2025 Fusetti, ChiaraCaruso, EnricoGiacomelli, AndreaCossu, Maria VittoriaPetri, FrancescoAntinori, SpinelloGori, AndreaMoschese, Davide + Article (author) -
Fostemsavir to overcome drug–drug interactions in heavily treatment-experienced people with HIV and cancer 2024 Andrea GiacomelliGiacomo PozzaDavide Moschese + Article (author) -
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 2024 Mileto, DavideBianchi, MicolSalari, FedericaBracchitta, FiorenzaGagliardi, GloriaFenizia, ClaudioBiasin, MaraMicheli, ValeriaMoschese, DavideAntinori, SpinelloGori, AndreaD'Arminio Monforte, AntonellaGismondo, Maria Rita + Article (author) -
Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort 2024 Moschese, DavideGiacomelli, AndreaRusconi, StefanoAntinori, Spinello + Article (author) -